Karolinska Development

Conny Bogentoft

CEO - CEO

Kontaktperson

PhD in Medicinal Chemistry, Associate Professor in Pharmaceutical Chemistry. Has, with more than 30 years' experience of pharmaceutical industry, as senior R&D management positions and as a member of board of directors for a number of companies, demonstrated his ability to successfully plan, implement and develop clinical and business strategies. Previous appointments include Vice President of Astra Arcus, President of Kabi Invent, Research Director at Aco Läkemedel, and Chairman of the Swedish Academy of Pharmaceutical Sciences.

Number of shares held in Karolinska Development AB: 29 433.